Burning Rock, a provider of next-generation sequencing diagnostics solutions for precision medicine in oncology, has raised RMB 850 million (over $125 million) in Series C funding. GIC led the round with participation from LYFE Capital, CMB International Capital, Lilly Asia Ventures, Sequoia Capital China and T&Brothers Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: